NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

Clinical trial NCT00053989 · COMPLETED

Trial details

NCT number: NCT00053989
Sponsor: Roswell Park Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Fanconi Anemia Aplastic Anemia

Start date: 2002-01-29
Primary completion: 2018-07-19
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.